高纯氩气
Search documents
侨源股份 诚信立本创新驱动 在工业气体赛道奋力奔跑
Shang Hai Zheng Quan Bao· 2025-12-12 19:25
侨源股份生产区域一角 ◎记者 李少鹏 "工业气体被誉为'工业的血液',下游企业生产线一旦启动,就离不开稳定的高纯气体供应,容不得半 点马虎。"近日,侨源股份主要负责人告诉上海证券报记者,在气体行业打拼,技术实力是立身之本, 客户口碑是发展之魂,唯有以诚信筑牢根基、以创新驱动升级,才能在激烈竞争中实现长远发展。 宁德时代、通威股份、东方电气……一连串的客户名单,彰显出侨源股份在工业气体领域奋斗二十余载 的"硬实力"。公司不仅稳居川渝地区行业标杆地位,更以"区域深耕+全国布局"的战略步伐,向全国乃 至国际市场稳步迈进。 诚信立本 夯实川渝核心市场优势 川渝地区作为西部产业高地,新能源、半导体、生物医药等新兴产业集群蓬勃发展,带动工业气体需求 年均稳步增长,成为行业竞争的核心区域之一。 面对制造业转型升级与特种气体需求激增的行业机遇,侨源股份在巩固川渝优势的同时,以"稳健布局 +精准转型"激活高质量发展新动能。 全国化布局的首站,公司精准落子福建。两套分别达25000Nm3/h和40000Nm3/h的空分生产线相继投 产,以现场制气模式满足闽光钢铁、宝钢德盛等核心客户需求,同时依托富余液态气产能辐射周边市 场,成功 ...
侨源股份(301286.SZ):不直接从事火箭燃料业务
Ge Long Hui· 2025-12-10 07:11
Core Viewpoint - The company, Qiaoyuan Co., Ltd. (301286.SZ), is not directly involved in rocket fuel business but is a leading supplier of industrial gases in China, which are essential for high-end precision manufacturing, including aerospace manufacturing [1] Group 1: Company Overview - Qiaoyuan Co., Ltd. offers a range of products including high-purity oxygen, high-purity nitrogen, high-purity argon, and specialty gases [1] - The company positions itself as a crucial provider of "industrial blood" for high-end manufacturing sectors [1] Group 2: Industry Insights - The booming commercial aerospace industry is expected to create stable demand for ultra-high purity gases [1] - This demand will help the company strengthen its product certification and brand advantages in the high-end market [1] - The company aims to continuously monitor and actively seize opportunities in strategic emerging industries, including commercial aerospace [1]
侨源股份Q3净利6343.57万元,同比增长16.88%
Ju Chao Zi Xun· 2025-10-23 10:25
Core Insights - Q3 2025 report shows company achieved operating revenue of 267.24 million yuan, a year-on-year increase of 5.57% [2][3] - Net profit for Q3 reached 63.44 million yuan, up 16.88% year-on-year [2][3] - For the first three quarters of 2025, operating revenue totaled 797.56 million yuan, reflecting an 8.75% increase [2][3] Financial Performance - Q3 net profit attributable to shareholders was 63.44 million yuan, with a 16.88% increase compared to the same period last year [2][3] - The net profit excluding non-recurring gains and losses for Q3 was 62.88 million yuan, up 15.42% year-on-year [2][3] - For the first three quarters, net profit attributable to shareholders was 181.86 million yuan, a significant increase of 40.54% [2][3] Operational Highlights - Company specializes in the research, production, sales, and service of high-purity gases, including high-purity oxygen, nitrogen, argon, and medical oxygen [2][3] - The company has the largest full liquid air separation gas production line in Southwest China, with production bases in Dujiangyan and Wenchuan, and additional bases in Meishan, Jintang, and Deyang [4] Strategic Initiatives - Company is actively expanding production capacity in Jintang and Pengzhou, focusing on high-purity electronic specialty gases, medical gases, and rare gases like krypton and xenon [5] - The strategic focus aims to meet the growing demand in high-end markets such as semiconductors, biomedicine, and new materials [5]
侨源股份:前三季度归母净利润增逾四成至1.81亿元
Zhong Guo Zheng Quan Bao· 2025-10-23 03:49
Core Viewpoint - Q3 2025 financial report of Qiaoyuan Co., Ltd. shows significant growth in revenue and net profit, indicating strong operational performance and market demand for high-purity gases [1][2]. Financial Performance - For the first three quarters of 2025, the company achieved a revenue of 797 million yuan, a year-on-year increase of 8.75% - The net profit attributable to shareholders reached 181 million yuan, up 40.54% year-on-year - The net cash flow from operating activities was 152 million yuan, reflecting a growth of 16.01% - In Q3 alone, the company reported a revenue of 267 million yuan, a 5.57% increase year-on-year, and a net profit of 63 million yuan, which is a 16.88% increase year-on-year [1]. Business Operations - Qiaoyuan Co., Ltd. specializes in the research, production, sales, and service of high-purity gases, with a comprehensive supply and service network established over 20 years - The product range includes high-purity oxygen, nitrogen, argon, medical oxygen, food nitrogen, industrial oxygen, carbon dioxide, hydrogen, various electronic gases, and mixed gases, catering to traditional industries like metallurgy and emerging sectors such as new energy and biomedicine [1][2]. Production Capacity and Expansion - In Sichuan, the company operates the largest liquid air separation gas production line in Southwest China, with multiple production bases including Dujiangyan, Wenchuan, Meishan, Jintang, and Deyang - In Fujian, the company has two air separation gas production lines with capacities of 25,000 Nm³/h and 40,000 Nm³/h respectively - The company is actively expanding production capacity in Jintang and Pengzhou, focusing on high-purity electronic gases, medical gases, and rare gases to meet the growing demand in high-end markets [2]. Strategic Investments - In August 2025, Qiaoyuan Co., Ltd. signed an investment cooperation agreement to invest 302 million yuan in building a specialty gas production base in Chengdu's new materials industrial park - This project is expected to add over 80,000 tons of specialty gas production capacity annually, including electronic-grade and medical-grade carbon dioxide [2].
侨源股份专注工业气体行业稳健发展 2025年前三季度实现净利润1.81亿元
Zheng Quan Ri Bao Wang· 2025-10-22 12:59
Core Insights - Sichuan Qiaoyuan Gas Co., Ltd. reported a revenue of 797 million yuan for the first three quarters of 2025, representing an 8.75% year-on-year increase, and a net profit of 181 million yuan, up 40.54% year-on-year [1] - In Q3 alone, the company achieved a revenue of 267 million yuan, a 5.57% increase year-on-year, and a net profit of approximately 63.44 million yuan, reflecting a 16.88% growth year-on-year [1] Group 1: Company Overview - Established in 2002, the company specializes in the production and sales of industrial gases, with a comprehensive supply and service network covering various gas types including high-purity oxygen, nitrogen, argon, medical oxygen, and carbon dioxide [1] - The company serves traditional industries such as metallurgy and chemicals, as well as emerging sectors like new energy, semiconductors, and biomedicine [1] Group 2: Market Position and Strategy - The diverse range of gas products allows the company to serve multiple industries, helping to mitigate market risks and providing stable revenue sources [2] - The company has the largest liquid air separation gas production line in Southwest China and is expanding its production capacity with new bases in Meishan, Jintang, and Deyang [2] - A recent investment of 302 million yuan will establish a special gas production base in Chengdu, expected to add over 80,000 tons of specialty gas capacity annually [2] Group 3: Industry Trends and Future Prospects - The company is strategically positioned to serve both traditional and emerging industries, creating a dual-driven development model [3] - In the military sector, the company focuses on the research and production of high-purity, high-reliability specialty gases, supporting national high-end manufacturing and supply chain initiatives [3] - The company has already supplied products to key units in aerospace, nuclear industry, and other critical sectors [3]
侨源股份(301286.SZ):核心产品与技术自主可控,不依赖外部厂商
Ge Long Hui· 2025-10-15 07:47
Core Viewpoint - Qiaoyuan Co., Ltd. is a comprehensive gas supplier focused on the research, production, sales, and service of high-purity gases, with a fully controlled production capability from air separation to product delivery [1] Group 1: Company Overview - The company specializes in high-purity gases, including high-purity oxygen, high-purity nitrogen, high-purity argon, medical oxygen, food nitrogen, and industrial oxygen [1] - The core products and technologies of the company are independently controllable and do not rely on external manufacturers [1]
侨源股份(301286.SZ):在氦气方面,公司已开展相关贸易业务
Ge Long Hui· 2025-10-15 07:47
Core Viewpoint - The company, Qiaoyuan Co., Ltd. (301286.SZ), is a comprehensive gas supplier focused on the research, production, sales, and service of high-purity gases, including high-purity oxygen, nitrogen, argon, medical oxygen, food nitrogen, industrial oxygen, and various electronic gases [1] Company Overview - The company specializes in high-purity gas development and has initiated trade activities related to helium [1]
侨源股份:在氦气方面,公司已开展相关贸易业务
Mei Ri Jing Ji Xin Wen· 2025-10-15 07:43
Core Viewpoint - The company, Qiaoyuan Co., Ltd. (301286.SZ), is a comprehensive gas supplier focused on the research, production, sales, and service of high-purity gases, and has initiated trade activities related to helium gas [1]. Company Overview - Qiaoyuan Co., Ltd. specializes in high-purity gas development and production, offering products such as high-purity oxygen, high-purity nitrogen, high-purity argon, medical oxygen, food nitrogen, industrial oxygen, and various electronic gases [1]. - The company has confirmed that it has started relevant trading activities concerning helium gas [1].
专注工业气体领域 侨源股份上半年净利润同比增长57.79%
Zheng Quan Ri Bao Wang· 2025-08-27 07:48
Group 1 - The core viewpoint of the articles highlights that Qiaoyuan Gas achieved significant growth in both revenue and net profit in the first half of 2025, with a revenue of 529 million yuan, representing a year-on-year increase of 10.43%, and a net profit of 117 million yuan, reflecting a year-on-year growth of 57.79% [1][2] - Qiaoyuan Gas has established a comprehensive and reliable gas supply and service network, providing a wide range of products including high-purity oxygen, nitrogen, argon, medical oxygen, and various electronic gases, catering to both traditional industries and emerging sectors such as renewable energy and semiconductors [1] - The growth in Qiaoyuan Gas's net profit is particularly notable within the industrial gas sector, attributed to the surge in demand from the renewable energy and semiconductor industries, which has driven sales of high-purity gases [1][2] Group 2 - Among the six A-share listed companies in the industrial gas sector, five have reported positive revenue growth in the first half of 2025, with three companies achieving revenue growth exceeding 10% [1] - The industrial gas industry is experiencing a mixed performance in profitability, with Qiaoyuan Gas and Guangzhou Guanggang Gas Energy both reporting net profits exceeding 100 million yuan, while other companies like Jin Hong Gas have seen significant declines in net profit [2] - The industrial gas sector faces challenges such as intensified market competition, fluctuating raw material prices, and increasing environmental regulations, but the rapid development of emerging industries presents new market opportunities [2]
侨源股份拟3亿投建生产基地扩产 产销两旺半年净利最高预增61.26%
Chang Jiang Shang Bao· 2025-08-05 23:49
Core Viewpoint - Qiaoyuan Co., Ltd. (301286.SZ) is enhancing its core business competitiveness by investing 302 million yuan to establish a special gas production base, aiming to upgrade medical gas capacity and enter strategic emerging fields such as semiconductor manufacturing and new displays [1][2][3]. Investment and Project Details - The company signed an investment cooperation agreement with the Chengdu New Materials Industry Functional Zone Management Committee to invest 302 million yuan in a special gas production base [2]. - The project will be implemented in two phases: Phase 1 involves an investment of approximately 152 million yuan to build facilities for producing 20,000 tons/year of electronic-grade and medical-grade carbon dioxide, along with hydrogen recovery and purification [2]. - Phase 2 will require about 150 million yuan to establish additional production lines for electronic-grade medical carbon dioxide and ultra-pure ammonia, pending further agreements [2][3]. Market Position and Business Expansion - Qiaoyuan Co., Ltd. is the largest liquid air separation gas supplier in Southwest China, focusing on the production and sales of industrial gas products [1][6]. - The company aims to enhance its market advantage by increasing its medical gas production capacity to meet the growing demand in biopharmaceuticals and high-end medical devices [2][3]. Financial Performance and Projections - The company forecasts a net profit of 100 million to 120 million yuan for the first half of 2025, representing a year-on-year growth of 34.38% to 61.26% [1][7]. - The expected non-recurring gains will impact net profit by approximately 8.7 million yuan [8]. - The growth in performance is attributed to expanded gas business scale, increased production and sales volume, revenue growth, and improved gross margins [8]. Strategic Acquisitions - In January, the company announced plans to acquire a controlling stake in Deyang Hongchen Chemical Co., Ltd. for no more than 200 million yuan, aiming to expand its product offerings in the carbon dioxide sector [3][4]. - However, the acquisition was terminated due to a lack of consensus among the parties involved, with no party bearing liability for the termination [4].